FILTRIX Logo FILTRIX Find Your Edge β†’
Sector Report β€” Open SIC 2836 Β· 128 tickers

Biological Products, (No Diagnostic Substances)

SIC 2836 128 tickers analyzed 3,547 total alerts

Tickers
128
In this sector
Total alerts
3,547
Trade-Ideas signal history
Avg win rate
44.0%
Sector baseline
Avg gain
-0.54%
Per-alert expectancy

πŸ“ˆ Sector Performance by Timeframe

5-Minute

Avg Gain: -0.41%
Win Rate: 39.9%

15-Minute

Avg Gain: -0.59%
Win Rate: 41.2%

30-Minute

Avg Gain: -0.62%
Win Rate: 41.5%

60-Minute

Avg Gain: -0.79%
Win Rate: 42.0%

EOD

Avg Gain: -0.31%
Win Rate: 55.4%

MFE/MAE

Avg MFE: +6.67%
Avg MAE: -2.76%

πŸ“‹ Biological Products, (No Diagnostic Substances) Stocks (100)

All tickers in SIC 2836 with Trade-Ideas alert data, sorted by alert count.

# Ticker Company Market Cap Alerts Avg Win Rate Avg 5min MFE Action
1 DNA Ginkgo Bioworks Holdings, Inc. $544.8M 436 43.2% -0.59% +4.00% View β†’
2 OCGN Ocugen, Inc. Common Stock $497.6M 332 38.4% -0.63% +3.63% View β†’
3 NVAX Novavax Inc $1.58B 312 44.0% -0.27% +5.20% View β†’
4 MRNA Moderna, Inc. Common Stock $21.14B 173 50.0% +0.07% +3.82% View β†’
5 RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock $1.67B 147 44.8% -0.46% +4.58% View β†’
6 GILD Gilead Sciences Inc $167.54B 138 57.2% +0.10% +1.26% View β†’
7 PALI Palisade Bio, Inc. Common Stock $321.8M 118 42.1% -0.18% +9.75% View β†’
8 OTLK Outlook Therapeutics, Inc. Common Stock $29.3M 84 53.8% -0.01% +10.10% View β†’
9 AMGN Amgen Inc $181.60B 82 53.4% +0.03% +1.16% View β†’
10 IBRX ImmunityBio, Inc. Common Stock $8.50B 79 44.6% -0.97% +9.39% View β†’
11 SGMO SANGAMO THERAPEUTICS INC - 75 44.8% +0.12% +9.76% View β†’
12 PLX Protalix BioTherapeutics, Inc. Common Stock $153.9M 64 44.7% -0.23% +4.59% View β†’
13 IOVA Iovance Biotherapeutics, Inc. Common Stock $1.59B 63 43.5% -0.33% +4.85% View β†’
14 SNTI Senti Biosciences Holdings, Inc. Common Stock $30.2M 57 42.1% -0.80% +17.26% View β†’
15 XFOR X4 Pharmaceuticals, Inc. Common Stock $409.3M 57 38.2% -1.96% +8.62% View β†’
16 CELZ Creative Medical Technology Holdings, Inc. Common Stock $8.4M 51 42.2% -0.16% +9.61% View β†’
17 CHRS Coherus Oncology, Inc. Common Stock $263.8M 47 42.1% -0.37% +6.39% View β†’
18 TVGN Tevogen Bio Holdings Inc. Common Stock $29.2M 44 35.0% -0.26% +12.36% View β†’
19 BIIB Biogen Inc. Common Stock $29.43B 43 43.7% -0.38% +1.24% View β†’
20 ATRA Atara Biotherapeutics, Inc $83.5M 41 59.6% +0.56% +11.12% View β†’
21 CGTX Cognition Therapeutics, Inc. Common Stock $105.6M 40 38.5% -0.94% +8.30% View β†’
22 DBVT DBV Technologies S.A. $1.18B 39 45.5% -0.03% +6.61% View β†’
23 AGEN Agenus Inc. $142.9M 39 51.3% -0.53% +5.35% View β†’
24 CRIS Curis Inc $22.0M 33 35.2% -0.96% +6.76% View β†’
25 TSHA Taysha Gene Therapies, Inc. Common Stock $1.97B 32 39.4% -0.56% +9.76% View β†’
26 SLXN Silexion Therapeutics Corp Ordinary Shares $2.4M 30 42.7% -1.23% +12.55% View β†’
27 TNYA Tenaya Therapeutics, Inc. Common Stock $217.0M 30 38.7% -0.48% +7.07% View β†’
28 INAB IN8bio, Inc. Common Stock $15.8M 29 42.0% -0.66% +10.13% View β†’
29 SCLX Scilex Holding Company Common Stock $47.9M 29 44.8% -0.75% +7.03% View β†’
30 HUMA Humacyte, Inc. Common Stock $202.0M 25 44.8% -0.39% +7.22% View β†’
31 BCRX BioCryst Pharmaceuticals Inc $2.24B 25 60.0% -0.21% +6.68% View β†’
32 SLDB Solid Biosciences Inc. Common Stock $759.8M 25 54.4% -0.46% +9.05% View β†’
33 DTIL Precision BioSciences, Inc. Common Stock $211.6M 24 42.0% -0.70% +4.55% View β†’
34 CADL Candel Therapeutics, Inc. Common Stock $638.9M 24 49.9% +1.30% +15.67% View β†’
35 CRSP CRISPR Therapeutics AG $5.10B 23 47.8% -0.34% +4.61% View β†’
36 BCDA BioCardia, Inc. Common Stock $12.3M 23 37.3% -0.08% +8.59% View β†’
37 CVM Cel-Sci Corporation $10.1M 23 44.3% +0.39% +14.95% View β†’
38 CCCC C4 Therapeutics, Inc. $350.5M 23 57.4% +0.93% +16.24% View β†’
39 CRDF Cardiff Oncology, Inc. Common Stock $112.1M 22 39.4% +1.06% +9.83% View β†’
40 IVVD Invivyd, Inc. Common Stock $421.4M 20 40.0% -1.59% +21.23% View β†’
41 JSPR Jasper Therapeutics, Inc. Common Stock $25.5M 20 51.0% +0.37% +17.19% View β†’
42 BDTX Black Diamond Therapeutics, Inc. Common Stock $162.2M 20 24.0% -1.25% +6.13% View β†’
43 AIM AIM ImmunoTech Inc. $2.4M 19 35.1% -0.19% +5.34% View β†’
44 IKT Inhibikase Therapeutics, Inc. Common Stock $253.5M 17 38.5% -0.97% +8.23% View β†’
45 CABA Cabaletta Bio, Inc. Common Stock $591.9M 16 33.8% -1.14% +12.54% View β†’
46 CRBU Caribou Biosciences, Inc. Common Stock $201.3M 16 30.0% -1.02% +4.77% View β†’
47 PHGE BiomX Inc. $6.5M 15 49.7% +0.08% +11.53% View β†’
48 CLDI Calidi Biotherapeutics, Inc. $2.8M 15 30.7% -2.21% +13.97% View β†’
49 ADMA ADMA Biologics, Inc. $1.95B 14 57.1% +0.27% +6.88% View β†’
50 ALGS Aligos Therapeutics, Inc. Common Stock $40.0M 14 45.4% -2.25% +8.20% View β†’
51 SANA Sana Biotechnology, Inc. Common Stock $907.2M 14 45.7% +1.47% +8.65% View β†’
52 NBIX Neurocrine Biosciences Inc $15.67B 14 65.7% +0.14% +1.75% View β†’
53 QNCX Quince Therapeutics, Inc. Common Stock $20.5M 14 26.2% -2.24% +7.08% View β†’
54 AVXL Anavex Life Sciences $283.6M 13 23.1% -1.47% +5.25% View β†’
55 EDIT Editas Medicine, Inc. Common Stock $286.9M 13 43.1% -0.94% +6.19% View β†’
56 BCAB BioAtla, Inc. Common Stock $7.5M 13 26.5% -1.38% +8.39% View β†’
57 VIR Vir Biotechnology, Inc. Common Stock $1.59B 12 25.0% -1.46% +4.22% View β†’
58 SABS SAB Biotherapeutics, Inc. Common Stock $254.4M 12 42.7% -2.22% +14.60% View β†’
59 IMVT Immunovant, Inc. Common Stock $5.83B 12 56.7% +0.71% +8.78% View β†’
60 SRZN Surrozen, Inc. Common $356.0M 11 54.0% -0.50% +14.11% View β†’
61 KOD Kodiak Sciences Inc Common Stock $2.47B 11 60.0% +0.02% +13.78% View β†’
62 NMRA Neumora Therapeutics, Inc. Common Stock $352.0M 10 61.3% +0.65% +8.94% View β†’
63 HALO Halozyme Therapeutics, Inc. $8.41B 10 30.2% -1.07% +1.45% View β†’
64 ABOS Acumen Pharmaceuticals, Inc. Common Stock $179.1M 10 28.0% -0.70% +8.74% View β†’
65 LCTX Lineage Cell Therapeutics, Inc. $331.6M 10 20.4% -0.71% +3.29% View β†’
66 FDMT 4D Molecular Therapeutics, Inc. Common Stock $540.5M 10 32.0% -2.37% +6.07% View β†’
67 TCRX TScan Therapeutics, Inc. Common Stock $75.2M 10 53.1% +0.22% +25.40% View β†’
68 RVMD Revolution Medicines, Inc. Common Stock $30.98B 9 51.1% -2.20% +4.88% View β†’
69 FATE Fate Therapeutics, Inc. $261.6M 9 55.6% +3.69% +14.54% View β†’
70 AUTL Autolus Therapeutics plc American Depositary Share $425.8M 8 22.5% -0.53% +3.79% View β†’
71 BEAM Beam Therapeutics Inc. Common Stock $3.25B 8 55.0% +0.14% +8.05% View β†’
72 RLAY Relay Therapeutics, Inc. Common Stock $2.48B 8 42.5% +0.17% +8.40% View β†’
73 TECH Bio-Techne Corp. $7.42B 8 47.9% -0.00% +1.24% View β†’
74 ALLO Allogene Therapeutics, Inc. Common Stock $793.6M 8 27.5% +0.55% +6.56% View β†’
75 PMCB PharmaCyte Biotech, Inc. Common Stock $8.5M 7 20.0% -0.30% +2.05% View β†’
76 PCVX Vaxcyte, Inc. Common Stock $7.80B 7 51.4% +0.64% +6.08% View β†’
77 PASG Passage Bio, Inc. Common Stock $16.1M 7 65.7% +0.12% +14.14% View β†’
78 EXEL Exelixis Inc $12.43B 7 65.7% -0.11% +1.54% View β†’
79 ZURA Zura Bio Limited Class A Ordinary Shares $450.7M 6 43.3% -0.10% +16.82% View β†’
80 SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares $2.1M 6 27.3% +2.64% +10.82% View β†’
81 TIL Instil Bio, Inc. Common Stock $54.9M 6 60.0% +0.68% +5.13% View β†’
82 DNLI Denali Therapeutics Inc. Common Stock $3.09B 6 33.3% -1.06% +4.83% View β†’
83 STRO Sutro Biopharma, Inc. $677.8M 6 36.7% -1.31% +6.30% View β†’
84 TWST Twist Bioscience Corporation Common Stock $3.48B 6 36.7% -0.76% +4.84% View β†’
85 INBX Inhibrx Biosciences, Inc. Common Stock $1.59B 6 64.7% +0.47% +6.34% View β†’
86 ENTX Entera Bio Ltd. Ordinary Shares $68.1M 6 28.0% -0.96% +9.40% View β†’
87 SRRK Scholar Rock Holding Corporation Common Stock $5.89B 5 32.0% +0.26% +9.98% View β†’
88 ACLX Arcellx, Inc. Common Stock $3.91B 5 28.0% -1.21% +4.45% View β†’
89 VOR Vor Biopharma Inc. Common Stock $892.4M 5 52.0% +2.16% +23.07% View β†’
90 REPL Replimune Group, Inc. $337.7M 5 68.0% -1.10% +7.54% View β†’
91 MGX Metagenomi Therapeutics, Inc. Common Stock $50.8M 5 40.0% +3.16% +23.51% View β†’
92 TARS Tarsus Pharmaceuticals, Inc. Common Stock $2.57B 4 25.0% -1.94% +1.96% View β†’
93 CGEM Cullinan Therapeutics, Inc. Common Stock $992.5M 4 15.0% -1.77% +2.69% View β†’
94 RGNX REGENXBIO Inc. $528.6M 4 30.0% -2.90% +2.05% View β†’
95 INKT MiNK Therapeutics, Inc. Common Stock $56.8M 4 41.7% -3.04% +11.47% View β†’
96 PROK ProKidney Corp. Class A Ordinary Shares $252.7M 4 35.0% -1.14% +8.42% View β†’
97 CMPX Compass Therapeutics, Inc. Common Stock $336.8M 4 25.0% -2.00% +18.76% View β†’
98 ALEC Alector, Inc. Common Stock $239.8M 4 10.0% -3.15% +3.21% View β†’
99 KLTO Klotho Neurosciences, Inc. Common Stock $23.7M 4 20.0% +0.45% +10.33% View β†’
100 TARA Protara Therapeutics, Inc. Common Stock $283.6M 4 40.0% -0.06% +10.04% View β†’

πŸš€ Scan for Alpha in Biological Products, (No Diagnostic Substances)

Don't trade the whole basket.
Use FILTRIX to isolate the top performing stocks among the 128 companies in this sector. Filter by MFE, Volume, and Win Rate instantly.

Find Best Setups β†’

πŸ“Š Biological Products, (No Diagnostic Substances) Sector Intelligence

⚑ High Volatility Sector

The Biological Products, (No Diagnostic Substances) sector (SIC 2836) aggregates data from 128 stocks. With an average Maximum Favorable Excursion (MFE) of +6.67%, this sector is highly aggressive, suited for experienced volatility traders looking for explosive moves.

πŸ“ˆ Statistical Expectancy

Across 3,547 analyzed alerts, the sector shows a 44.0% Win Rate with an average gain of -0.54%.

⚠️ This suggests a difficult trading environment where strict stock selection is critical. Focus on the top performers within this sector.

πŸ† Sector Leader

The strongest statistical performer in this group is currently NBIX , boasting a 65.7% win rate across 14 alerts.

This significantly outperforms the sector average (44.0%), making it a primary watchlist candidate for traders seeking edge in this space.